Clinical trial
Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women
NCT01741974 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2005
- Completion date
- October 31, 2012
- Enrollment
- 340 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, menopausal syndrome